The Research and Development team at Ribometrix focuses on harnessing advanced structural analysis of RNA to drive the discovery of innovative drug candidates. This multidisciplinary group, consisting of experts in medicinal chemistry, RNA biology, and translational medicine, collaborates to translate scientific insights into actionable therapeutic strategies, advancing the company’s internal drug pipeline and fostering partnerships with leading biopharmaceutical firms. Their goal is to develop small molecules that effectively modulate RNA and protein functions linked to human diseases.
View all